Ernexa Therapeutics Inc. Payments of Ordinary Dividends, Preferred Stock and Preference Stock
Ernexa Therapeutics Inc. (ERNA) reported Payments of Ordinary Dividends, Preferred Stock and Preference Stock of $8.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock · last filed 2025-11-07
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2024-09-30 was $0.00.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2023-12-31 was $8.00K, a 0.00% change year-over-year.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2023-09-30 was $0.00.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for the quarter ending 2022-12-31 was $8.00K, a 0.00% change year-over-year.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for fiscal 2023 was $16.00K, a 0.00% change from fiscal 2022.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for fiscal 2022 was $16.00K, a 100.00% increase from fiscal 2021.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for fiscal 2021 was $8.00K.
- Ernexa Therapeutics Inc. payments of ordinary dividends, preferred stock and preference stock for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
| Period end | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 3 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 6 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 9 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 12 month | Payments of Ordinary Dividends, Preferred Stock and Preference Stock 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $8.00K 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | $8.00K 10-Q · filed 2025-08-13 | ||||
| 2023-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $8.00K derived: sum of 2 quarters · filed 2025-03-12 | $16.00K 10-K · filed 2025-03-12 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $8.00K 10-Q · filed 2024-08-13 | ||||
| 2022-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $8.00K derived: sum of 2 quarters · filed 2024-03-14 | $16.00K 10-K · filed 2024-03-14 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $8.00K 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $8.00K 10-Q · filed 2023-08-11 | ||||
| 2021-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $8.00K derived: sum of 2 quarters · filed 2023-03-20 | $8.00K 10-K · filed 2023-03-20 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | ||||
| 2020-12-31 | -$8.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | -$8.00K derived: sum of 2 quarters · filed 2022-07-01 | $0.00 10-K/A · filed 2022-07-01 | $16.00K 10-K · filed 2021-03-11 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $8.00K 10-Q · filed 2020-11-13 | |||
| 2020-06-30 | $8.00K 10-Q · filed 2020-08-07 | ||||
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $8.00K derived: sum of 2 quarters · filed 2021-03-11 | $16.00K 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $8.00K 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $8.00K 10-Q · filed 2020-08-07 | ||||
| 2018-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $8.00K derived: sum of 2 quarters · filed 2020-03-19 | $16.00K 10-K · filed 2020-03-19 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $8.00K 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | $8.00K 10-Q · filed 2018-08-06 | ||||
| 2017-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $8.00K derived: sum of 2 quarters · filed 2019-03-22 | $16.00K 10-K · filed 2019-03-22 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $8.00K 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $8.00K 10-Q · filed 2018-08-06 | ||||
| 2016-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $8.00K derived: sum of 2 quarters · filed 2018-03-09 | $16.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $8.00K 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | $8.00K 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |